See accompanying notes to unaudited condensed financial
statements.
See accompanying notes to unaudited condensed financial
statements.
See accompanying notes to unaudited condensed financial
statements.
See accompanying notes to unaudited condensed financial
statements.
Notes to Condensed Financial Statements
(unaudited)
Note 1 – Description of Organization and Business Operations
Global Partner Acquisition Corp II (the “Company”) was
incorporated under the laws of the Cayman Islands as an exempted company on November 3, 2020. The Company was formed for the purpose of
effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one
or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a)
of the Securities Act of 1933, as amended, or the “Securities Act,” as modified by the Jumpstart Our Business Startups Act
of 2012 (the “JOBS Act”).
At September 30, 2022, the Company had not commenced any operations.
All activity for the period from November 3, 2020 (inception) to September 30, 2022 relates to the Company’s formation and the initial
public offering (“Public Offering”) described below and, subsequent to the Public Offering, identifying and completing a suitable
Business Combination. The Company will not generate any operating revenues until after completion of its Initial Business Combination,
at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Public Offering.
All dollar amounts are rounded to the nearest thousand dollars.
Sponsor and Public Offering:
The Company’s sponsor is Global Partner Sponsor II LLC, a
Delaware limited liability company (the “Sponsor”). On January 14, 2021, the Company consummated a $300,000,000 Public
Offering (Note 3) and a $8,350,000 private placement (Note 4). Upon the closing of the Public Offering and the private placement,
$300,000,000 was deposited in a trust account (the “Trust Account”)
The Trust Account:
The funds in the Trust Account can only be invested in U.S. government
treasury bills with a maturity of one hundred and eighty-five (185) days or less or in money market funds meeting certain conditions under
Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U.S. government treasury obligations. Funds will remain
in the Trust Account until the earlier of (i) the consummation of its Initial Business Combination or (ii) the distribution
of the Trust Account as described below. The remaining funds outside the Trust Account may be used to pay for business, legal and accounting
due diligence on prospective acquisition targets, legal and accounting fees related to regulatory reporting obligations, payment for services
of investment professionals and support services, continued listing fees and continuing general and administrative expenses.
The Company’s amended and restated memorandum and articles
of association provides that, other than the withdrawal of interest to pay tax obligations, if any, less up to $100,000 of interest
to pay dissolution expenses, none of the funds held in trust will be released until the earliest of: (a) the completion of the
initial Business Combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote
to amend the Company’s amended and restated memorandum of association (i) to modify the substance or timing of the
Company’s obligation to redeem 100% of the public shares if the Company does not complete the Initial Business Combination
within 24 months from the closing of the Public Offering, or January 14, 2023, (the “Combination Period”), or
(ii) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity, and
(c) the redemption of the public shares if the Company is unable to complete the Initial Business Combination within the Combination Period, subject to applicable law, or during any extended time that we have to
consummate a Business Combination beyond 24 months as a result of a shareholder vote to amend the Company’s amended and
restated articles of incorporation. The proceeds deposited in the Trust Account could become subject to the claims of creditors, if
any, which could have priority over the claims of the Company’s public shareholders.
Business Combination:
The Company’s management has broad discretion with respect to
the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering
are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein,
“Target Business” is one or more target businesses that together have a fair market value equal to at least 80% of the balance
in the Trust Account (excluding the deferred underwriting commission and taxes payable on interest earned on the trust account) at the
time of signing a definitive agreement in connection with the Company’s Initial Business Combination. There is no assurance that
the Company will be able to successfully effect a Business Combination.
The Company, after signing a definitive agreement for a Business Combination,
will either (i) seek shareholder approval of the Business Combination at a meeting called for such purpose in connection with which
shareholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal
to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation
of the Initial Business Combination, including interest earned on funds held in the trust account and not previously released to pay income
taxes, or (ii) provide shareholders with the opportunity to have their shares redeemed by the Company by means of a tender offer
(and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on
deposit in the Trust Account as of two business days prior to commencement of the tender offer, including interest earned on funds held
in the trust account and not previously released to pay income taxes. The decision as to whether the Company will seek shareholder approval
of the Business Combination or will allow shareholders to sell their shares in a tender offer will be made by the Company, solely in its
discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would
otherwise require the Company to seek shareholder approval unless a vote is required by the rules of the Nasdaq Capital Market. If the
Company seeks shareholder approval, it will complete its Business Combination only if a majority of the outstanding Class A and Class B
ordinary shares voted are voted in favor of the Business Combination. However, in no event will the Company redeem its public shares in
an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case,
the Company would not proceed with the redemption of its public shares and the related Business Combination, and instead may search for
an alternate Business Combination.
If the Company holds a shareholder vote or there is a tender offer
for shares in connection with a Business Combination, a public shareholder will have the right to redeem its shares for an amount in cash
equal to its pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation
of the Initial Business Combination, including interest earned on funds held in the trust account and not previously released to pay income
taxes. As a result, such Class A ordinary shares are recorded at redemption amount and classified as temporary equity upon the completion
of the Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification
(“ASC”) 480, “Distinguishing Liabilities from Equity.” The amount in the Trust Account is initially funded at
$10.00 per public Class A ordinary share ($300,000,000 held in the Trust Account divided by 30,000,000 public shares).
The Company will have until the end of the Combination Period to
complete its Initial Business Combination or until the end of any extension period that may be proposed to and approved by the
Company’s shareholders in the form of an amendment to the Company’s amended and restated memorandum and articles of
association. If the Company does not complete a Business Combination within this period of
time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible,
but not more than ten business days thereafter, redeem the public Class A ordinary shares for a per share pro rata portion of
the Trust Account, including interest earned on funds held in the trust account and not previously released to pay income taxes
(less up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such
redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining shareholders, as
part of its plan of dissolution and liquidation. The initial shareholders have entered into letter agreements with us, pursuant to
which they have waived their rights to participate in any redemption with respect to their Founders Shares; however, if the initial
shareholders or any of the Company’s officers, directors or affiliates acquire Class A ordinary shares in or after the
Public Offering, they will be entitled to a pro rata share of the Trust Account with respect to the Class A ordinary shares so
acquired upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within
the Combination Period. In the event of such distribution, it is possible that the per share value of the residual assets remaining
available for distribution (including Trust Account assets) will be less than the price per Unit (as defined below in Note 3) in the
Public Offering.
Note 2 – Summary of Significant Accounting Policies
Basis of Presentation:
The accompanying unaudited condensed interim financial statements of
the Company are presented in U.S. dollars and in conformity with accounting principles generally accepted in the United States of America
(“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all
adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation
of the financial position and the results of operations and cash flows for the periods presented. Certain information and disclosures
normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. Interim
results are not necessarily indicative of results for a full year or any future periods.
The accompanying unaudited condensed interim financial statements should
be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s audited
financial statements included in the Company’s Annual Report on Form 10-K filed with the SEC on March 18, 2022.
Mandatory Liquidation and Going Concern:
At September 30, 2022, the Company has approximately $247,000 in
cash and approximately $3,514,000 in negative working capital. The Company has incurred significant costs and may incur additional
costs in pursuit of its Business Combination. Further, if the Company cannot complete a Business Combination within the Combination
Period, it could be forced to wind up its operations and liquidate unless it receives an extension approval from its shareholders.
These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time
within one year after the date that the unaudited condensed financial statements are issued. The Company’s plan to deal with
these uncertainties is to preserve cash by deferring payments with anticipated cooperation from its service providers (except for
its registered public accounting firm), to draw down on the working capital loans made available to it by the Sponsor and to
complete a Business Combination within the Combination Period. The proximity to January 14, 2023 increases the difficulty of completing
a Business Combination. As such, there is no assurance that the Company’s plans to consummate a Business Combination will be
successful or successful within the Combination Period. The condensed financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
Emerging Growth Company:
Section 102(b)(1) of the JOBS Act exempts emerging growth companies
from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not
had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act)
are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out
of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election
to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting
standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth
company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
Net Income per Ordinary Share:
Net income per ordinary share is computed by dividing net income applicable
to ordinary shareholders by the weighted average number of ordinary shares outstanding for the period. The Company has not considered
the effect of the warrants sold in the Public Offering and Private Placement to purchase an aggregate of 15,566,667 Class A ordinary shares
in the calculation of diluted income per ordinary share, since their inclusion would be anti-dilutive under the treasury stock method
and are dependent on future events. As a result, diluted income per ordinary share is the same as basic income per ordinary share for
the period.
The Company complies with the accounting and disclosure requirements
of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary
shares and Class B ordinary shares. Income and losses are shared pro rata among the two classes of shares. Net income (loss) per ordinary
share is calculated by dividing the net income (loss) by the weighted average number of ordinary shares outstanding during the respective
period. The changes in redemption value that are accreted to Class A common stock subject to redemption (see below) is representative
of fair value and therefore is not factored into the calculation of earnings per share.
The following table reflects the earnings per share after allocating
income between the shares based on outstanding shares.
| |
Three months ended | | |
Nine months ended | |
| |
September 30, 2022 | | |
September 30, 2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| | |
| |
Basic and diluted net income per ordinary share: | |
| | |
| | |
| | |
| |
Allocation of income – basic and diluted | |
$ | 1,699,000 | | |
$ | 425,000 | | |
$ | 9,761,000 | | |
$ | 2,440,000 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average ordinary shares: | |
| 30,000,000 | | |
| 7,500,000 | | |
| 30,000,000 | | |
| 7,500,000 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income per ordinary share | |
$ | 0.06 | | |
$ | 0.06 | | |
$ | 0.33 | | |
$ | 0.33 | |
| |
Three months ended | | |
Nine months ended | |
| |
September 30, 2021 | | |
September 30, 2021 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| | |
| |
Basic and diluted net income per ordinary share: | |
| | |
| | |
| | |
| |
Allocation of income – basic and diluted | |
$ | 1,205,000 | | |
$ | 301,000 | | |
$ | 3,340,000 | | |
$ | 835,000 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average ordinary shares: | |
| 30,000,000 | | |
| 7,500,000 | | |
| 27,845,000 | | |
| 7,500,000 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income per ordinary share | |
$ | 0.04 | | |
$ | 0.04 | | |
$ | 0.12 | | |
$ | 0.12 | |
Concentration of Credit Risk:
Financial instruments that potentially subject the Company to concentrations
of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal Deposit Insurance Corporation
coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed
to significant risks on such accounts.
Cash and Cash Equivalents:
The Company considers all highly liquid instruments with original maturities
of three months or less when acquired, to be cash equivalents. The Company had no cash equivalents at September 30, 2022 or December 31,
2021.
Fair Value Measurements
The Company complies with FASB ASC 820, Fair Value Measurements and
Disclosures, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial
assets and liabilities that are re-measured and reported at fair value at least annually. As of September 30, 2022 and December 31, 2021,
the carrying value of cash, prepaid expenses, accounts payable, accrued expenses and notes payable – related party approximate their
fair values primarily due to the short-term nature of the instruments.
Fair value is defined as the price that would be received for sale
of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes
a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority
to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable
inputs (Level 3 measurements). These tiers include:
|
● |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|
● |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
|
● |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
In some circumstances, the inputs used to measure fair value might
be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its
entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Use of Estimates:
The preparation of condensed financial statements in conformity with
GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the condensed balance sheet and the reported amounts of expenses during
the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the
estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statement,
which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One
of the more significant estimates included in these condensed financial statements is the determination of the fair value of the warrant
liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could
differ significantly from those estimates.
Offering Costs:
The Company complies with the requirements of the FASB ASC 340-10-S99-1
and SEC Staff Accounting Bulletin (SAB) Topic 5A— “Expenses of Offering.” Costs incurred in connection with preparation
for the Public Offering totaled approximately $17,054,000 including $16,500,000 of underwriters’ discount. Such costs were allocated
among the temporary equity and warrant liability components, based on their relative fair-value. Upon completion of the Public Offering
approximately $16,254,000 has been charged to temporary equity for the temporary equity components and approximately $800,000 has been
charged to other expense for the warrant liability.
Class A Ordinary Shares Subject to Possible Redemption:
As discussed in Note 3, all of the 30,000,000 Class A ordinary shares
sold as part of the Units in the Public Offering contain a redemption feature that allows for the redemption under the Company’s
liquidation or tender offer/shareholder approval provisions. In accordance with FASB ASC 480, redemption provisions not solely within
the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve
the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although
the Company had not specified a maximum redemption threshold, its articles of association provide that in no event will it redeem its
Public Shares in an amount that would cause its net tangible assets (shareholders’ equity) to be less than $5,000,001. However,
because all of the Class A ordinary shares are redeemable, all of the shares are recorded as Class A ordinary shares subject to redemption
on the enclosed condensed balance sheet.
The Company recognizes changes immediately as they occur and adjusts
the carrying value of the securities at the end of each reporting period. Increases or decreases in the carrying amount of redeemable
Class A ordinary shares are affected by adjustments to additional paid-in capital. Accordingly, at September 30, 2022 and December 31,
2021, 30,000,000 of the 30,000,000 Public Shares were classified outside of permanent equity. Class A ordinary shares subject to redemption
consist of:
Gross proceeds of Public Offering | |
$ | 300,000,000 | |
Less: Proceeds allocated to Public Warrants | |
| (14,100,000 | ) |
Offering costs | |
| (16,254,000 | ) |
Plus: Accretion of carrying value to redemption value at Public Offering | |
| 30,354,000 | |
Subtotal at inception and at December 31, 2022 | |
| 300,000,000 | |
Accretion of carrying value to redemption value since Public Offering | |
| 2,021,000 | |
Class A ordinary shares subject to possible redemption | |
$ | 302,021,000 | |
Income Taxes:
FASB ASC 740 prescribes a recognition threshold and a measurement attribute
for the balance sheet recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to
be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s
management determined that the Cayman Islands is the Company’s major tax jurisdiction. There were no unrecognized tax benefits as
of September 30, 2022 and December 31, 2021. The Company recognizes interest and penalties related to unrecognized tax benefits as income
tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2022 or December 31, 2021. The Company
is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is subject to income tax examinations by major taxing authorities since inception.
The Company is considered a Cayman Islands exempted company and is
presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s
tax provision was zero for the period presented. The Company’s management does not expect that the total amount of unrecognized
tax benefits will materially change over the next twelve months.
Warrant Liability:
The Company accounts for warrants as either equity-classified or liability-classified
instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in “FASB ASC 480,
“Distinguishing Liabilities from Equity” (“ASC 480”) and ASC 815, “Derivatives and Hedging” (“ASC
815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition
of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including
whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment,
which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period
end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity
classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued
or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as a liability
at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the
warrants are recognized as a non-cash gain or loss on the statement of operations. Costs associated with issuing the warrants accounted
for as liabilities are charged to operations when the warrants are issued.
Recent Accounting Pronouncements:
In August 2020, the FASB issued Accounting Standards Update (“ASU”)
2020-06, “Debt — Debt with Conversion and Other Options” (Subtopic 470-20) and “Derivatives and Hedging —
Contracts in Entity’s Own Equity” (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial
instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from
convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an
entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that
are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the
requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied
on a full or modified retrospective basis. The Company is currently evaluating the impact that the pronouncement will have on the condensed
financial statements.
Management does not believe that any other recently issued, but not
yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial
statements.
Subsequent Events:
The Company evaluated subsequent events and transactions that occurred
after the date of the condensed balance sheet through the date that the condensed financial statements were available to be issued and
has concluded that all such events that would require adjustment or disclosure in the condensed financial statement have been recognized
or disclosed.
Note 3 – Public Offering
On January 14, 2021, the Company consummated the Public Offering and
sale of 30,000,000 units at a price of $10.00 per unit (the “Units”). Each Unit consists of one share of the Company’s
Class A ordinary shares, $0.0001 par value, one-sixth of one detachable redeemable warrant (the “Detachable Redeemable Warrants”)
and the contingent right to receive, in certain circumstances, in connection with the Business Combination, one-sixth of one distributable
redeemable warrant for each public share that a public shareholder holds and does not redeem in connection with the Company’s Initial
Business Combination (the “Distributable Redeemable Warrants”). Each whole Redeemable Warrant offered in the Public Offering
is exercisable to purchase one of the Company’s Class A ordinary shares. Only whole Redeemable Warrants may be exercised. Under
the terms of the warrant agreement, the Company has agreed to use its commercially reasonable efforts to file a new registration statement
under the Securities Act, following the completion of the Company’s Initial Business Combination covering the Class A ordinary shares
issuable upon the exercise of warrants. No fractional shares will be issued upon exercise of the Redeemable Warrants. If, upon exercise
of the Redeemable Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round
down to the nearest whole number the number of Class A ordinary shares to be issued to the Redeemable Warrant holder. Each Redeemable
Warrant will become exercisable on the later of 30 days after the completion of the Company’s Initial Business Combination
or 12 months from the closing of the Public Offering and will expire five years after the completion of the Company’s Initial Business
Combination or earlier upon redemption or liquidation. However, if the Company does not complete its Initial Business Combination on or
prior to the end of the Combination Period, the Redeemable Warrants will expire at the end of such period. If the Company is unable to
deliver registered Class A ordinary shares to the holder upon exercise of a Redeemable Warrant during the exercise period, there
will be no net cash settlement of these Redeemable Warrants and the Redeemable Warrants will expire worthless, unless they may be exercised
on a cashless basis in the circumstances described in the warrant agreement. Once the Redeemable Warrants become exercisable, the Company
may redeem the outstanding Redeemable Warrants in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’
prior written notice of redemption, only in the event that the last sale price of the Class A ordinary shares equals or exceeds $18.00
per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice
of redemption to the Redeemable Warrant holders, and that certain other conditions are met. Once the Redeemable Warrants become exercisable,
the Company may also redeem the outstanding Redeemable Warrants in whole and not in part at a price of $0.10 per Warrant upon a minimum
of 30 days’ prior written notice of redemption, only in the event that the closing price of the Class A ordinary shares
equals or exceeds $10.00 per share on the trading day prior to the date on which the Company sends the notice of redemption, and that
certain other conditions are met. If the closing price of the Class A ordinary shares is less than $18.00 per share (as adjusted) for
any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the
warrant holders, the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public
Warrants, as described above. If issued, the Distributable Redeemable Warrants are identical to the Redeemable Warrants and together represent
the Public Warrants.
The Company had granted the underwriters a 45-day option to purchase
up to 2,500,000 Units to cover any over-allotments, at the Public Offering price less the underwriting discounts and commissions and such
option was exercised in full at the closing of the Public Offering and included in the 30,000,000 Units sold on January 14, 2021.
The Company paid an underwriting discount of 2.0% of the per Unit price,
$6,000,000, to the underwriters at the closing of the Public Offering and there is a deferred underwriting fee of 3.5% of the per Unit
price, $10,500,000, which is payable upon the completion of the Company’s Initial Business Combination.
Note 4 – Related Party Transactions
Founder Shares:
During 2020, the Sponsor purchased 7,187,500 Class B ordinary
shares (the “Founder Shares”) for $25,000 (which amount was paid directly for organizational costs and costs of the Public
Offering by the Sponsor on behalf of the Company), or approximately $0.003 per share. In January 2021, the Company effected a share capitalization
resulting in there being an aggregate of 7,500,000 Founder Shares issued. The Founder Shares are substantially identical to the Class A
ordinary shares included in the Units sold in the Public Offering except that the Founder Shares automatically convert into Class A
ordinary shares at the time of the Initial Business Combination, or at any time prior thereto at the option of the holder, and are subject
to certain transfer restrictions, as described in more detail below, and the Founder Shares are subject to vesting as follows: 50% upon
the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement)
exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances.
Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled.
The Sponsor agreed to forfeit up to 625,000 Founder Shares to the extent
that the over-allotment option was not exercised in full by the underwriters. The underwriters’ exercised their over-allotment option
in full and therefore such shares are no longer subject to forfeiture.
In addition to the vesting provisions of the Founder Shares discussed
in Note 8, the Company’s initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares until the
earlier of (A) one year after the completion of the Company’s Initial Business Combination, or (B), subsequent to the Company’s
Initial Business Combination, if (x) the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00
per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day period commencing at least 150 days after the Company’s Initial Business Combination or (y) the date
on which the Company completes a liquidation, merger, share exchange or other similar transaction after the Initial Business Combination
that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other
property.
Private Placement Warrants:
The Sponsor purchased from the Company an aggregate of 5,566,667 warrants
at a price of $1.50 per warrant (a purchase price of $8,350,000) in a private placement that occurred simultaneously with the completion
of the Public Offering (the “Private Placement Warrants”). Each Private Placement Warrant entitles the holder to purchase
one Class A ordinary share at $11.50 per share. The purchase price of the Private Placement Warrants was added to the proceeds from
the Public Offering, net of expenses of the offering and working capital to be available to the Company, to be held in the Trust Account
pending completion of the Company’s Initial Business Combination. The Private Placement Warrants (including the Class A ordinary
shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after
the completion of the Initial Business Combination and they will be non-redeemable so long as they are held by the Sponsor or its permitted
transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement
Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being
sold in the Public Offering. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the Redeemable
Warrants being sold as part of the Units in the Public Offering and have no net cash settlement provisions.
If the Company does not complete a Business Combination, then the
proceeds from the sale of the Private Placement Warrants that were placed into the trust account will be part of the liquidating
distribution from the trust account to the public shareholders and the Private Placement Warrants issued to the Sponsor will expire
worthless.
Registration Rights:
The Company’s initial shareholders and the holders of the Private
Placement Warrants are entitled to registration rights pursuant to a registration and shareholder rights agreement. These holders will
be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale
under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities
in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any
such registration statements. There will be no penalties associated with delays in registering the securities under the registration and
shareholder rights agreement.
Notes Payable – Related Party:
Sponsor loans - In November 2020, the Sponsor agreed to
loan the Company up to an aggregate of $300,000 by drawdowns of not less than $1,000 each against the issuance of an unsecured promissory
note (the “Note” or “Notes payable – related party”) to cover expenses related to the Public Offering. The
Note was non-interest bearing and payable on the earlier of September 30, 2021 or the completion of the Public Offering. As of the closing
date of the Public Offering, the Company had drawn down approximately $199,000 under the Note, including approximately $49,000 of costs
paid directly by the Sponsor, for costs related to costs of the Public Offering. On January 14, 2021, upon closing of the Public Offering,
all amounts outstanding under the Note were repaid and the Note is no longer available to the Company.
Sponsor working capital loans - On
August 1, 2022, the Company issued a promissory note (the “Note” or “Notes payable – related party”) in
the principal amount of up to $2,000,000 to its Sponsor. The Note was issued in connection with advances the Sponsor may make to the Company
for expenses reasonably related to its business and the consummation of the Business Combination. The Note bears no interest and is due
and payable upon the earlier to occur of (i) January 14, 2023 and (ii) the effective date of a merger, capital share exchange, asset acquisition,
share purchase, reorganization or similar business combination, involving the Company and one or more businesses (the “Business
Combination”). As of September 30, 2022, the outstanding principal balance under the note was $400,000.
Administrative Services Agreement:
The Company has agreed to pay $25,000 a month to the Sponsor for office
space and rent and for the services to be provided by one or more investment professionals, creation and maintenance of the Company’s
website, and miscellaneous additional services. Services commenced on the date the securities are first listed on the Nasdaq Capital Market
and will terminate upon the earlier of the consummation by the Company of an Initial Business Combination or the liquidation of the Company.
Approximately $75,000 was paid and charged to general and administrative expenses during each of the three months ended September 30,
2022 and 2021. Approximately $225,000 and $213,000, respectively, was paid and charged to general and administrative expenses during each
of the nine months ended September 30, 2022 and 2021 for this agreement and there were no amounts payable or accrued at September 30,
2022 or December 31, 2021.
Note 5 – Accounting for Warrant Liability and Fair
Value of Warrants
At September 30, 2022 and December 31, 2021, there were 15,566,667
warrants outstanding including 10,000,000 Public Warrants and 5,566,667 Private Placement Warrants.
The Company’s warrants are not indexed to the Company’s
ordinary shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing
of a fixed-for-fixed option on equity shares. As such, the company’s warrants are accounted for as warrant liabilities which are
required to be valued at fair value at each reporting period.
The Company has recorded approximately $800,000 of costs to operations
upon issuance of the warrants to reflect warrant issuance costs in the nine months ended September 30, 2021.
The following table presents information about the Company’s
warrant liabilities that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021 and indicates the
fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
Description | |
At September 30, 2022 | | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Warrant Liabilities: | |
| | |
| | |
| | |
| |
Public Warrants | |
$ | 600,000 | | |
$ | 600,000 | | |
$ | - | | |
$ | - | |
Private Placement Warrants | |
| 334,000 | | |
| - | | |
| 334,000 | | |
| - | |
Warrant liability at September 30, 2022 | |
$ | 934,000 | | |
$ | 600,000 | | |
$ | 334,000 | | |
$ | - | |
Description | |
At
December 31, 2021 | | |
Quoted Prices in Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Warrant Liabilities: | |
| | |
| | |
| | |
| |
Public Warrants | |
$ | 8,300,000 | | |
$ | 8,300,000 | | |
$ | - | | |
$ | - | |
Private Placement Warrants | |
| 4,620,000 | | |
| - | | |
| 4,620,000 | | |
| - | |
Warrant liability at December 31, 2021 | |
$ | 12,920,000 | | |
$ | 8,300,000 | | |
$ | 4,620,000 | | |
$ | - | |
At September 30, 2022 and December 31, 2021, the Company valued its
(a) public warrants based on the closing price at September 30, 2022 and December 31, 2021, respectively, in an active market and (b)
its private placement warrants based on the closing price of the public warrants since they are similar instruments.
The following table presents the changes in the fair value of warrant
liabilities during the nine months ended September 30, 2022:
| |
Public | | |
Private Placement | | |
Warrant Liabilities | |
Fair value measurement on December 31, 2021 | |
$ | 8,300,000 | | |
$ | 4,620,000 | | |
$ | 12,920,000 | |
Change in fair value | |
| (7,700,000 | ) | |
| (4,286,000 | ) | |
| (11,986,000 | ) |
Fair value as of September 30, 2022 | |
$ | 600,000 | | |
$ | 334,000 | | |
$ | 934,000 | |
The following table presents the changes in the fair value of warrant
liabilities during the nine months ended September 30, 2021:
| |
Public | | |
Private Placement | | |
Warrant Liabilities | |
Fair value measurement on December 31, 2020 | |
$ | - | | |
$ | - | | |
$ | - | |
Fair value at inception of the warrants on January 14, 2021 | |
| 14,100,000 | | |
| 7,849,000 | | |
| 21,949,000 | |
Change in fair value | |
| (5,300,000 | ) | |
| (2,950,000 | ) | |
| (8,250,000 | ) |
Fair value as of September 30, 2021 | |
$ | 8,800,000 | | |
$ | 4,899,000 | | |
$ | 13,699,000 | |
The warrant liabilities are not subject to qualified hedge accounting.
The Company’s policy is to record transfers at the end of the
reporting period.
The public warrants were transferred from Level 3 to Level 1, and the
private placement warrants were transferred from Level 3 to Level 2, during the nine months ended September 30 ,2021.
Note 6 – Trust Account and Fair Value Measurement
The Company complies with FASB ASC 820, Fair Value Measurements, for
its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets
and liabilities that are re-measured and reported at fair value at least annually.
Upon the closing of the Public Offering and the Private Placement,
a total of $300,000,000 was deposited into the Trust Account. The proceeds in the Trust Account may be invested in either U.S. government
treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment
Company Act of 1940, as amended, and that invest solely in U.S. government treasury obligations.
At September 30, 2022 and December 31, 2021, the Trust Account was
invested in a money market fund meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, and that
invests solely in U.S. government treasury obligations. The Company classifies its U.S. government treasury bills and equivalent securities
(when it owns them) as held-to-maturity in accordance with FASB ASC 320, “Investments – Debt and Equity Securities.”
Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Money market funds
are valued at market.
The following tables present information about the Company’s
assets that are measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 and indicates the fair value
hierarchy of the valuation techniques the Company utilized to determine such fair value. Since all of the Company’s permitted investments
at September 30, 2022 and December 31, 2021 consisted of money market funds meeting certain conditions under Rule 2a-7 under the
Investment Company Act of 1940 which invest only in direct U.S. government treasury obligations, fair values of its investments are determined
by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assts or liabilities as follows:
| |
| | |
Quoted Price | |
| |
Carrying value at | | |
Prices in Active | |
Description | |
September 30, 2022 | | |
Markets (Level 1) | |
Assets: | |
| | |
| |
Money Market Fund | |
$ | 302,021,000 | | |
$ | 302,021,000 | |
Total | |
$ | 302,021,000 | | |
$ | 302,021,000 | |
| |
| | |
Quoted Price | |
| |
Carrying value at | | |
Prices in Active | |
Description | |
December 31, 2021 | | |
Markets (Level 1) | |
Assets: | |
| | |
| |
Money Market Fund | |
$ | 300,075,000 | | |
$ | 300,075,000 | |
Total | |
$ | 300,075,000 | | |
$ | 300,075,000 | |
Note 7 – Shareholders’ Equity (Deficit)
Ordinary Shares:
The authorized ordinary shares of the Company include 500,000,000 Class A
ordinary shares, par value, $0.0001, and 50,000,000 Class B ordinary shares, par value, $0.0001, or 550,000,000 ordinary shares in
total. The Company may (depending on the terms of the Business Combination) be required to increase the authorized number of shares at
the same time as its shareholders vote on the Business Combination to the extent the Company seeks shareholder approval in connection
with its Business Combination. Except with respect to matters pertaining to directors prior to the Business Combination, holders of the
Company’s Class A and Class B ordinary shares vote together as a single class and are entitled to one vote for each
Class A and Class B ordinary share.
The Founder Shares are subject to vesting as follows: 50% upon the
completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder
return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement,
could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing
of the Business Combination will be cancelled.
At September 30, 2022 and December 31, 2021 there were 7,500,000 Class B
ordinary shares issued and outstanding, and -0- and -0- Class A ordinary shares issued and outstanding (after deducting 30,000,000 Class
A ordinary shares subject to possible redemption at each condensed balance sheet date).
Preference Shares:
The Company is authorized to issue 5,000,000 Preference shares, par
value $0.0001, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s
board of directors. At September 30, 2022 and December 31, 2021, there were no Preference shares issued or outstanding.
Note 8 – Commitments and Contingencies
Business Combination Costs
In connection with identifying an Initial Business Combination candidate
and negotiating an Initial Business Combination, the Company has entered into, and may enter into additional, engagement letters or agreements
with various consultants, advisors, professionals and others. The services under these engagement letters and agreements are material
in amount and in some instances include contingent or success fees. Contingent or success fees (but not deferred underwriting commission)
would be charged to operations in the quarter that an Initial Business Combination is consummated. In most instances (except with respect
to the Company’s independent registered public accounting firm), these engagement letters and agreements are expected to specifically
provide that such counterparties waive their rights to seek repayment from the funds in the Trust Account.
Risks and Uncertainties
COVID-19 — Management continues to evaluate the impact
of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the pandemic could have an effect
on the Company’s financial position, results of operations and/or search for a target company and/or a target company’s financial
position and results of its operations, the specific impact is not readily determinable as of the date of these condensed financial statements.
These condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Conflict in Ukraine — In February 2022, the Russian Federation
and Belarus commenced a military action against the country of Ukraine. As a result of this action, various nations, including the United
States, have instituted economic sanctions against the Russian Federation and Belarus. The impact of this action and related sanctions
on the world economy are not determinable as of the date of these condensed financial statements.